-

Rapidly growing ( plated )™ Skin Science Expands U.S. Manufacturing with State-of-the-Art Facility to Meet Surging Demand

Nation’s largest cosmetic exosome site to scale production of proprietary Renewosome™ technology

ROCHESTER, Minn.--(BUSINESS WIRE)--( plated )™ Skin Science, a breakthrough skincare brand powered by exosome science, today announced the opening of its new 14,000 square foot manufacturing facility in Rochester, Minnesota. Built to exclusively produce the brand’s proprietary platelet-derived exosomes, known as Renewosome™ technology, this expansion represents a major milestone as ( plated )™ responds to triple-digit growth in demand.

Since launch, ( plated )™ has set a new standard for performance in medical grade skincare. The brand’s rapid adoption by top physicians and consumers alike has driven the need for increased production capacity, supply chain control, and manufacturing scale—all now delivered through this state-of-the-art U.S.-based facility.

“As demand for ( plated )™ surges, this new facility allows us to keep pace while upholding the scientific integrity and clinical-grade standards that set us apart,” said Alisa Lask, CEO of RION Aesthetics. “This isn’t just about scale—it’s about preserving the quality and consistency that define our brand as we lead the next generation of aesthetics.”

Key Highlights:

  • Built for Growth: 14,000 sq. ft. of dedicated manufacturing space designed to scale with the brand’s accelerating demand trajectory.
  • State-of-the-Art Purification Process: Proprietary technology ensures exceptional quality, consistency, and performance.
  • Clinical-Grade Quality & Compliance: Engineered to meet rigorous GMP standards and support commercial programs.
  • Strategic Location: Based in Rochester, MN to foster collaboration and scientific innovation with world-renowned research

With end-to-end manufacturing under one roof, ( plated )™ maintains full control over the production of platelet-derived exosomes—ensuring reliability, scalability, and rapid innovation. This facility enhances the ability to meet growing demand while laying the groundwork for future advancements.

About (plated)™ Skin Science

(plated)™ Skin Science is an internationally recognized aesthetics product line, spearheading the industry's shift towards scientifically grounded and innovative exosome-based solutions to improve the appearance of the skin and hair. This versatile product line, featuring products for anti-aging, post-procedure recovery, and fuller-looking hair, is powered by Renewosome™ technology, an award-winning blend of platelet-derived exosomes with powerful antioxidants. For more information, please visit platedskinscience.com.

Contacts

Franco Botta (botta@rionax.com)

Rion Aesthetics


Release Versions

Contacts

Franco Botta (botta@rionax.com)

More News From Rion Aesthetics

New BODY Serum from ( plated )® Skin Science Brings Regenerative Skincare to the Other 90% of Your Skin

ROCHESTER, Minn.--(BUSINESS WIRE)--( plated )® Skin Science, the #1 dermatologist-recommended exosome skincare brand developed by Rion Aesthetics, announced the launch of BODY Serum, extending its regenerative skincare platform beyond the face for the first time. Already recognized as a 2026 SHAPE Beauty Award winner, BODY Serum brings the brand’s proprietary platelet-derived exosome technology to the skin below the chin. While facial skincare has evolved into sophisticated, science-driven rout...

The Fastest-Growing Professional-Grade Skincare Brand ( plated )® Skin Science to Spotlight Its Scientific Edge at TD Cowen Summit

ROCHESTER, Minn.--(BUSINESS WIRE)--( plated ) Skin Science, the fastest-growing professional-grade skincare brand developed by Rion Aesthetics, will participate in the TD Cowen Glowing Ahead Summit: Beauty’s Evolution & Longevity as Luxury, taking place February 23–25, 2026, in New York City. Alisa Lask, Chief Executive Officer & Founder of Rion Aesthetics, will participate in a panel on February 24, where she will discuss the rapid commercial acceleration of ( plated ) Skin Science, re...

Rion Aesthetics Supports Initiation of the First U.S. Investigator-Initiated Clinical Trial of Dermal Injections with PEP™ Exosomes

ROCHESTER, Minn.--(BUSINESS WIRE)--Rion Aesthetics, an internationally recognized regenerative aesthetics company, today announced that the U.S. Food and Drug Administration (FDA) has allowed an Investigational New Drug (IND) application to proceed for a Phase 1 investigator-initiated trial evaluating Purified Exosome Product™ (PEP™) injected into the dermis. The study is sponsored and independently conducted by Clinical Testing Center of Beverly Hills and is being led by Dr. John H. Joseph, a...
Back to Newsroom